BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J. Abi‐Habib, Arthur E. Frankel|Molecular Cancer Therapeutics|2005Cited by 73